Literature DB >> 24016101

Fresh Pork and Porcine Reproductive and Respiratory Syndrome Virus: Factors Related to the Risk of Disease Transmission.

W Hall1, E Neumann2.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRS) is a highly infectious virus. Experimentally, the disease can be induced in naïve pigs by the oral, intranasal and intramuscular routes. Depending on the virulence of the strain of the virus and the age of the pig, peak viremia can occur within 7 days of infection, and live virus can be isolated from blood or lymph nodes for several months post-infection. Young pigs tend to develop higher titres of viremia than older pigs infected by the same route and dose with the same strain of virus. Porcine reproductive and respiratory syndrome virus survives in pork harvested from infected pigs for extended periods at temperatures of -20 or -70°C. In experimentally infected pigs, survival of PRRS virus in muscle held at 4°C has been demonstrated for at least 7 days, and infectivity of the virus in these samples was confirmed by bioassay. The optimal pH range for the survival of PRRS virus is thought to be 6.0 to 7.5. The elevated pH of non-meat tissues (generally one pH unit higher) is likely to favour extended survival of PRRS virus in pig carcasses from which all superficial and deep lymph nodes have not been removed. It is likely that exsanguinated carcasses held at 4°C retain sufficient blood or lymph tissue to contain infective doses of PRRS virus. Porcine reproductive and respiratory syndrome virus is rapidly inactivated by heat, providing a predictable method to ensure that pork tissues are free of viable virus and feeding of cooked swill or garbage should not constitute a risk to pigs. While the probability of viable PRRS virus being present in a pig carcass may be low, the risk is not zero. The importation of raw pork into countries where PRRS is not endemic represents a hazard with potentially severe economic consequences.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  disease transmission; pig; porcine reproductive and respiratory syndrome; pork; risk assessment; viruses

Mesh:

Year:  2013        PMID: 24016101     DOI: 10.1111/tbed.12163

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  6 in total

1.  Serological evidence of type 2 (North American genotype) porcine reproductive and respiratory syndrome virus in Nepal.

Authors:  Barun Kumar Sharma; Salina Manandhar; Brecht Devleesschauwer
Journal:  Trop Anim Health Prod       Date:  2015-12-28       Impact factor: 1.559

Review 2.  Is There a Risk for Introducing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Through the Legal Importation of Pork?

Authors:  Megan C Niederwerder; Raymond R R Rowland
Journal:  Food Environ Virol       Date:  2016-09-02       Impact factor: 2.778

3.  Porcine reproductive and respiratory syndrome virus (PRRSV) in pig meat.

Authors:  Philippe Raymond; Christian Bellehumeur; Malliga Nagarajan; Diane Longtin; Alexandra Ferland; Peter Müller; Rachel Bissonnette; Carole Simard
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

Review 4.  Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination.

Authors:  Emanuela Pileri; Enric Mateu
Journal:  Vet Res       Date:  2016-10-28       Impact factor: 3.683

5.  Epidemiological investigations of the introduction of porcine reproductive and respiratory syndrome virus in Chile, 2013-2015.

Authors:  Víctor Neira; Barbara Brito; Juan Mena; Marie Culhane; Maria Ignacia Apel; Vanessa Max; Patricio Perez; Valentina Moreno; Christian Mathieu; Magdalena Johow; Catalina Badia; Montserrat Torremorell; Rafael Medina; Rene Ortega
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

6.  Modeling suggests gene editing combined with vaccination could eliminate a persistent disease in livestock.

Authors:  Gertje Eta Leony Petersen; Jaap B Buntjer; Fiona S Hely; Timothy John Byrne; Andrea Doeschl-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.